Clínica y Salud
versión impresa ISSN 1130-5274
Aims: The relationship between ecstasy and affective psychological symptoms are still subject to debate. We aimed to examine the relationship between Ecstasy use and self-report depression, anxiety and schizotypy. Design: Data were collected via structured remote self-report questionnaires. Participants: Participants were split into three groups: a control group with no ecstasy use, a light ecstasy user group (<50 times), and a heavy ecstasy user group (>50 times). Measurements: Amount and patterns of ecstasy use were recorded, the Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) measured depression and anxiety respectively, and schizotypal traits were measured using the schizotypal Personality Questionnaire (SPQ). Findings: It was found that ecstasy use was associated with depression, anxiety and schizotypal trait scores. There was no relationship between these measures and the level of ecstasy use. Conclusions: Ecstasy use per se was associated with self-report depression and anxiety, replicating previous literature. Furthermore, ecstasy users reported more schizotypal traits, something which had not been investigated in any previous research.
Palabras clave : ecstasy; MDMA; 3, 4- methlenedioxymethamphatamine; depression; anxiety; schizotypy; serotonin.